The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 24, 2012

Filed:

Apr. 19, 2007
Applicants:

Keizo Sugasawa, Tokyo, JP;

Kenichi Kawaguchi, Tokyo, JP;

Takaho Matsuzawa, Tokyo, JP;

Ryushi Seo, Tokyo, JP;

Hironori Harada, Tokyo, JP;

Akira Suga, Tokyo, JP;

Tomoaki Abe, Tokyo, JP;

Hidenori Azami, Tokyo, JP;

Shunichiro Matsumoto, Tokyo, JP;

Takashi Shin, Tokyo, JP;

Masayuki Tanahashi, Tokyo, JP;

Toru Watanabe, Tokyo, JP;

Inventors:

Keizo Sugasawa, Tokyo, JP;

Kenichi Kawaguchi, Tokyo, JP;

Takaho Matsuzawa, Tokyo, JP;

Ryushi Seo, Tokyo, JP;

Hironori Harada, Tokyo, JP;

Akira Suga, Tokyo, JP;

Tomoaki Abe, Tokyo, JP;

Hidenori Azami, Tokyo, JP;

Shunichiro Matsumoto, Tokyo, JP;

Takashi Shin, Tokyo, JP;

Masayuki Tanahashi, Tokyo, JP;

Toru Watanabe, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5355 (2006.01); A61K 31/496 (2006.01); A61K 31/451 (2006.01); A61K 31/4535 (2006.01); A61K 31/426 (2006.01); C07D 413/14 (2006.01); C07D 211/32 (2006.01); C07D 211/46 (2006.01); C07D 277/24 (2006.01);
U.S. Cl.
CPC ...
Abstract

Provided is an agent for treating or preventing urinary frequency, urinary urgency and urinary, incontinence which are associated with overactive bladder, a lower urinary tract disease such as interstitial cystitis and chronic prostatitis accompanied by lower urinary tract pain, and various diseases accompanied by pain. A novel azolecarboxamide derivative in which an azole ring such as thioazole or oxazole is bonded to a benzene ring, pyridine ring or pyrimidine ring through carboxamide was confirmed to have a potent trkA receptor-inhibitory activity and found to be an agent for treating or preventing lower urinary tract disease and various diseases accompanied by pain, which is excellent in efficacy and safety, and thus the present invention was accomplished.


Find Patent Forward Citations

Loading…